Category: Disclosures

[Disclosure] Hanwha Ocean (042660) – Other Major Management Matters (Voluntary Disclosure) / 2024-11-21

November 21, 2024August 9, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary This filing discloses that Hanwha Ocean finalized a transaction closing agreement with Hanwha Corporation on November 21, 2024, regarding joint liability obligations, cost settlements, and indemnity terms for wind power projects being acquired from Hanwha Corporation. 📊 [Key Disclosure Highlights & Summary] [Amended Details: Commitment Letter…

Disclosures, Shipbuilding

[Disclosure] Hanwha Ocean (042660) – Decision on Guarantees for Debt of Others / 2024-11-21

November 21, 2024August 9, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary This filing details Hanwha Ocean’s decision to provide a KRW 180B debt guarantee in the form of a responsible completion commitment for the Ulsan liquid cargo tank terminal expansion project, covering potential damages if construction is not completed by the agreed deadline. 📊 [Key Disclosure Highlights…

Disclosures, Shipbuilding

[Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Presentation / 2024-11-21

November 21, 2024August 1, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary The company will participate in the ‘Citi Korea Tech Tour’ sponsored by Citi Securities to hold group IR meetings for major overseas institutional investors in Seoul. Key topics include launch plans for next-generation Fluxless TC Bonders, Hybrid Bonder development status and roadmap, and the 2025 US-led…

Semiconductors, Disclosures

[Disclosure] ALTEOGEN (196170) – Clarification on Rumors or News Reports (Unconfirmed) / 2024-11-21

November 21, 2024August 5, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Regarding media reports on a KRW 200B Redeemable Convertible Preferred Shares (RCPS) issuance, Alteogen clarified that while the issuance is under consideration, nothing has been concretely finalized and no lead manager contract has been executed with Shinhan Securities. 📊 [Key Disclosure Details & Financial Highlights] 📝…

Disclosures, Bio & Healthcare

[Disclosure] SK Square (402340) – Decision on Acquisition of Treasury Shares / 2024-11-21

November 21, 2024July 31, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary SK Square has decided to directly acquire 1,253,132 treasury shares on the open market, valued at approximately KRW 100B, as part of its shareholder return policy to enhance shareholder value. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Progress and…

Semiconductors, Disclosures

[Disclosure] SK Square (402340) – Decision on Retirement of Shares / 2024-11-21

November 21, 2024July 31, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary SK Square has decided to retire 1,201,904 common treasury shares (book value of approx. KRW 90.2B) within the dividend-payable profit limit on January 6, 2025. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Execution of Stock Retirement and Reflection of…

Semiconductors, Disclosures

[Disclosure] SK Square (402340) – Corporate Value-Up Plan / 2024-11-21

November 21, 2024July 31, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary SK Square has announced its 2024 Corporate Value-Up Plan, targeting a NAV discount rate below 50% and a PBR of over 1.0x by 2027. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Tracking Target Metric Achievement and Progress of Action…

Semiconductors, Disclosures

[Disclosure] Celltrion (068270) – Treasury Share Acquisition Decision / 2024-11-21

November 21, 2024August 6, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion decided to acquire approximately KRW 100 billion (583,431 common shares) worth of its own shares on the open market to stabilize its stock price and enhance shareholder value. The acquisition period runs from November 22, 2024, to February 21, 2025. 📊 Key Disclosure Content &…

Disclosures, Bio & Healthcare

[Disclosure] Celltrion (068270) – Domestic (MFDS) Marketing Authorization for Stoboclo & Osenvelt (CT-P41, Prolia & Xgeva Biosimilar) / 2024-11-21

November 21, 2024August 6, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion received marketing authorization from the Ministry of Food and Drug Safety (MFDS) for Stoboclo and Osenvelt (CT-P41), biosimilars referencing Prolia and Xgeva. 📊 Key Disclosure Content & Financial Highlights 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Marketing Authorization Official Reflection and Subsequent Disclosures…

Disclosures, Bio & Healthcare

[Disclosure] Hanwha Aerospace (012450) – (Correction) Acquisition of Shares in Other Corporation / 2024-11-21

November 21, 2024August 10, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Aerospace’s Singapore subsidiary (Hanwha Ocean SG Holdings) completed the tender offer acquiring a 95.15% stake in offshore structure maker Dyna-Mac Holdings and plans to proceed with compulsory acquisition for the remaining shares. 📊 [Key Disclosure Details & Summary of Figures] Key Corrections (Before Correction →…

Disclosures, Defense